A critical advance in cancer research is occurring with the use of mini-antibodies to reactivate mutated p53. This essential tumor suppressor protein is frequently disabled in various kinds of cancer, resulting https://bookmarksurl.com/story7635762/vhh-fragments-revive-the-p53-protein-new-potential-approach-for-tumor-management